International

Durham, NC, USA and SEOUL, South Korea, November 17, 2025 — Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and precision oncology, and Labcorp, a global leader of innovative and comprehensive laboratory services,...

TEL AVIV, Israel & GLASGOW, Scotland--(BUSINESS WIRE)--Nucleai, a leader in AI-powered spatial biology for precision medicine, and the University of Glasgow, a global leader in spatial proteomics and transcriptomics research, today...

November 10, 2025 -- Noul, Korea’s AI-based blood and cancer diagnostics company, said Monday it has signed an exclusive distribution agreement with Biomedica, a leading European medical device distributor, for its cervical cancer diagnostic...

PathGroup and Mindpeak: Collaboration accelerates AI adoption across one of the world’s largest fully digital laboratory networks HAMBURG, GERMANY, November 11, 2025 /EINPresswire.com/ -- Mindpeak, a global pioneer in AI-powered pathology...

Studies reveal how the Lunit SCOPE® suite identifies immunotherapy-responsive subtypes, standardizes immune phenotyping, and accelerates antibody-based target discovery SEOUL, South Korea, November 7, 2025 — Lunit (KRX:328130.KQ), a...

From Backlogs to Rapid Diagnosis: Diagnexia Secures Full UKAS Accreditation for End-to-End Histopathology OXFORD, UK – 04/11/2025 – Responding to increasing demand for reliable pathology reporting across the NHS, Diagnexia UK Limited...